Venlafaxine Hydrochloride
Pricing Report NDC 60505-3779-3

Latest NADAC: $0.12583 per EA · Effective Sep 19, 2018 · Est. package price $3.77 (30 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Venlafaxine Hydrochloride (NDC 60505-3779-3) is $0.12583 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 19, 2018.

As a provided by Apotex Corp., this medication is distributed in a 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.12583
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Sep 19, 2018
Billable Units
30 EA
Estimated Package Price
$3.77
Data Status
As of Oct 03, 2018
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
60505-3779-3
Description
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.11550 to $0.30536 per EA. Over this 5 years and 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.1155 - $0.3054
Market Volatility
164.38% Variance
Latest Trend
5.41%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jan 23, 2019 $0.11550 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 19, 2018 $0.12210 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 21, 2018 $0.11928 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 17, 2018 $0.12016 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 19, 2018 $0.12583 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 19, 2018 $0.12583 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 22, 2018 $0.13133 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 22, 2018 $0.13133 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 18, 2018 $0.12536 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 18, 2018 $0.12536 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 20, 2018 $0.12485 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 20, 2018 $0.12485 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026